AUG 26, 2019 8:20 AM PDT

New Gene Editing Technology to Combat Hereditary Diseases

WRITTEN BY: Annie Lennon

Until recently, many types of gene-editing methods were unable to target critical parts of DNA. Now however, researchers at the Salk Institute have developed a new method, known as SATI, able to target these areas better, and provide promise to treat a broad range of gene mutation conditions including Huntington’s disease. 

The CRISPR-Cas9 system is one of the most well-known gene editing tools. Generally effective in dividing cells, such as those in the skin or the gut, the CRISPR-Cas9-based gene-editing technology, known as HITI (for homology-independent targeted integration) works only on protein-coding regions, which account for only 2% of the genome. These regions, although responsible for making proteins, are otherwise outnumbered by non-coding regions (accounting for 98% of the genome), which decide how many proteins are made. 

Thus, researchers at the Salk Institute decided to create a tool to target these non-coding regions of the DNA. Called SATI (otherwise known as intercellular linearized Single homology Arm donor mediated intron-Targeting Integration), this new method builds upon the previous HITI method. It works by introducing a normal copy of the problematic gene into the non-coding region of the DNA before the mutation site (Salk Institute: 2019). This new gene then becomes a part of the genome alongside the old gene through one of multiple DNA repair pathways. Over time, this process leaves the person or animal in question without the negative effects of the original, mutated gene, and without the risk of having it fully replaced. 

To test this new method, the researchers tested SATI on living mice with progeria, a rare premature aging syndrome that also occurs in humans, caused by a mutation on the LMNA gene. Using SATI, they inserted a normal copy of the LMNA gene into the mice with progeria. They soon observed diminished signs of aging in multiple tissues, including the skin and the spleen, alongside an increase in lifespan by 45%, when compared to mice with progeria who were left untreated. In human terms, this lifespan extension would equal around a decade. 

A success, SATI is the first gene editing technology that targets non-coding regions of DNA in vivo, and that is capable of working in multiple tissue types. The researchers now aim to increase the number of cells that incorporate the new DNA to improve SATI’s efficiency. According to Reyna Hernandez-Benitez, co-first author of the paper: “Specifically, we will investigate the details of the cellular systems involved in DNA repair to refine the SATI technology even further for better DNA correction."

 

Sources 

 

Salk Institute: Science Daily 

Wellcome Trust

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
NOV 02, 2020
Microbiology
A Bacterial Virus Can Help Salmonella Spread
NOV 02, 2020
A Bacterial Virus Can Help Salmonella Spread
The Salmonella bacterium is to blame fora lot of foodborne infections, many of which cause only mild illness, though oth ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
NOV 09, 2020
Genetics & Genomics
Potential Problems with Liquid Biopsies
NOV 09, 2020
Potential Problems with Liquid Biopsies
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
DEC 29, 2020
Microbiology
How CRISPR Can Help Create a Vaccine for a Common Parasite
DEC 29, 2020
How CRISPR Can Help Create a Vaccine for a Common Parasite
The parasite Toxoplasma gondii is thought to infect a third of the people on the planet as well as a wide range of other ...
JAN 14, 2021
Genetics & Genomics
Identical Twins Aren't Exactly the Same
JAN 14, 2021
Identical Twins Aren't Exactly the Same
Identical, or monozygotic twins develop from one egg that splits into 2, so the embryos that develop independently from ...
Loading Comments...